Clinical Trials on Acquired Visual Field Defects

Total 1867 results

Merck Sharp & Dohme LLC

Completed

Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)

HIV Infections | Acquired Immunodeficiency Syndrome
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED)

HIV Infections | Acquired Immunodeficiency Syndrome
Coordinación de Investigación en Salud, Mexico
Instituto Mexicano del Seguro Social

Completed

Effect of Omega 3 Fatty Acids on Oxidative Stress in HIV Seropositive Patients

HIV/AIDS

Mexico
Makerere University
Rakai Health Sciences Program

Unknown

Demand Creation for Couples' HIV Counseling and Testing

HIV/AIDS
Johns Hopkins Bloomberg School of Public Health

Completed

Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth

HIV/AIDS

United States
Gilead Sciences

Completed

Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients

HIV Infections | Acquired Immunodeficiency Syndrome

United States
Boehringer Ingelheim

Completed

Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS

Acquired Immunodeficiency Syndrome
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)

Completed

HIV Prevention Intervention for Couples

Acquired Immunodeficiency Syndrome

United States
Kristine Patterson, MD
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Sex, Aging and Antiretroviral Pharmacokinetics

HIV Infections

United States
Avexa

Terminated

Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection

HIV Infections

Canada, United States, Australia, United Kingdom, Thailand, Germany, Italy, Israel, Belgium, Puerto Rico, Peru
International Partnership for Microbicides, Inc.

Completed

A Safety and Acceptability Study of a Vaginal Ring Microbicide Delivery Method

HIV Infections

South Africa, Tanzania
Centers for Disease Control and Prevention
University of North Carolina, Chapel Hill; Kamuzu Central Hospital

Completed

Breastfeeding, Antiretroviral, and Nutrition Study

HIV Infections

Malawi
University of Cologne

Completed

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

HIV Infections | Acquired Immunodeficiency Syndrome

Germany
Abbott

Completed

Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Once-Daily Drug Regimen for HIV-Infected Patients

HIV Infections | Acquired Immunodeficiency Syndrome

United States
National Institute of Allergy and Infectious Diseases...

Unknown

Resistance to HIV Infection

HIV Infections

United States
Instituto Nacional de Ciencias Medicas y Nutricion...
Instituto Mexicano del Seguro Social; National Council of Science and Technology...

Unknown

PI Vs. NNRTI Based Therapy for HIV Advanced Disease

Acquired Immunodeficiency Syndrome

Mexico
Oxo Chemie GmbH

Completed

A Study of WF 10 IV Solution in Patients With Advanced HIV Disease

HIV Infections

United States
Boehringer Ingelheim

Completed

An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease

HIV Infections

United States
Glaxo Wellcome

Completed

A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients

HIV Infections

United States
Gilead Sciences

Completed

A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection

HIV Infections

United States
Glaxo Wellcome

Completed

An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2

HIV Infections

United States
Glaxo Wellcome

Completed

A Study of 1592U89 in HIV-Infected Children

HIV Infections

United States
Columbia University
Fogarty International Center of the National Institute of Health

Completed

Blood-borne Infection Screening in an Afghan Antenatal Population

Contraception | Breast Feeding, Exclusive | Viral Hepatitis B | Effects of; Lack of Care of Infants

Afghanistan
University of California, San Diego
National Institute of Mental Health (NIMH)

Recruiting

Women SHINE: Addressing Syndemics and HIV Among Women Through Tech-Based Peer Engagement

HIV/AIDS

United States
Guangzhou 8th People's Hospital

Recruiting

Observational Study on Patients With HIV/AIDS(OSPWH) (OSPWH)

HIV Infections

China
Brown University
National Institute of Mental Health (NIMH)

Recruiting

Brief Acceptance-Based Retention Intervention for Newly Diagnosed HIV Patients

HIV/AIDS

United States
ANRS, Emerging Infectious Diseases

Recruiting

Evaluation of Third-line cART Regimen in Cambodia (3DICAM)

HIV/AIDS

Cambodia
Guangzhou 8th People's Hospital
Wuhan Union Hospital, China; LiuZhou People's Hospital; Tianjin Second People... and other collaborators

Recruiting

Simplified Treatment of Anti-retrovirus in China (C-STAR)

HIV/AIDS

China
Michele Staton
National Institute on Drug Abuse (NIDA)

Completed

Social Media HIV Prevention Intervention for High Risk Rural Women

HIV/AIDS

United States
University of Illinois at Chicago
National Institute on Minority Health and Health Disparities (NIMHD)

Completed

PHAT Life: Peer Versus Adult-Led HIV Prevention for Juvenile Offenders (PHATLife)

HIV/AIDS

United States
University of Pennsylvania
Bill and Melinda Gates Foundation; Innovations for Poverty Action; Impact Research...

Completed

Prize-linked Savings Initiatives for Promoting Better Health and Economic Outcomes in Kenya

HIV/AIDS

United States
Elizabeth Glaser Pediatric AIDS Foundation
Janssen, LP

Active, not recruiting

Characteristics and Outcomes of Patients Who Received Etravirine and/or Darunavir (NewHorizon)

HIV/AIDS

Cameroon, Kenya, Lesotho, Swaziland, Uganda
Instituto Nacional de Cardiologia de Laranjeiras
Rio de Janeiro State University

Completed

The Effects of Exercise Training in Vascular Function of Patients Living With HIV

HIV/AIDS

Brazil
Columbia University
Centers for Disease Control and Prevention; Ministry of Health, Swaziland

Completed

Swaziland HIV Incidence Measurement Survey 2 (SHIMS2)

HIV/AIDS

Swaziland
Massachusetts General Hospital
National Institute of Mental Health (NIMH)

Completed

Optimizing mHealth for Adherence Monitoring and Intervention (OAsIS)

HIV/AIDS

Uganda
University of Chicago
Centers for Disease Control and Prevention; Howard Brown Health Center; Chicago...

Completed

Navigating Insurance Coverage Expansion (NICE) (NICE)

HIV/AIDS

United States
New York University
National Institute on Drug Abuse (NIDA)

Completed

Peer-driven Intervention to Seek, Test & Treat Heterosexuals at High Risk for HIV (BCAP)

HIV/AIDS

United States
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Standardized Patient Encounters to Improve PrEP Counseling for Adolescent Girls and Young Women in Kenya (PrIYA-SP)

HIV/AIDS

Kenya
Centers for Disease Control and Prevention
Botswana Ministry of Health

Completed

Open Label Extension (OLE) of the TDF2 Study, Botswana (TDF2-OLE)

HIV Infections
International AIDS Vaccine Initiative

Completed

A Phase I Trial to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer Vaccine, Adjuvanted

HIV/AIDS

United States
Myanmar Oxford Clinical Research Unit
Institute of Tropical Medicine, Belgium; Medical Action Myanmar

Completed

PrEP Among MSM and TG in Myanmar (PrEP)

HIV Infections

Myanmar
Centre Hospitalier René Dubos

Completed

Life Experience of People Aged 60 and Over Living With HIV (PVVIH)

Virus-HIV

France
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Glaxo Wellcome

Completed

A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)

HIV Infections

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Abbott; Glaxo Wellcome

Terminated

The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants

HIV Infections
National Institute of Allergy and Infectious Diseases...

Completed

A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Glaxo Wellcome

Completed

A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Long Term Follow-Up of HIV Infected Patients Who Have Previously Participated in HIV Clinical Trials

HIV Infections

Clinical Trials on Acquired Visual Field Defects

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations